New and established topical corticosteroids in dermatology: clinical pharmacology and therapeutic use

B Brazzini, N Pimpinelli - American journal of clinical dermatology, 2002 - Springer
Currently, topical glucocorticosteroids are the most frequently used drugs in dermatologic
practice. Over the years, research has focused on strategies to optimize potency and, in …

The etiology of steroid cataract

ER James - Journal of Ocular Pharmacology and Therapeutics, 2007 - liebertpub.com
Steroid-induced posterior subcapsular cataracts (PSCs) exhibit three main distinctive
characteristics:(i) association only with steroids possessing glucocorticoid activity,(ii) …

Hypotensive lipid-containing biodegradable intraocular implants and related methods

PM Hughes - US Patent 7,799,336, 2010 - Google Patents
4. 85 3. 224 A 8, 1989 Man O for an extended period of time. The prostamide component 4s
63.457 A 9, 1989 g may be associated with a biodegradable polymer matrix. Such 4s65s46 …

[HTML][HTML] Pathogenesis of uveitic glaucoma

D Kalogeropoulos, VCT Sung - Journal of current glaucoma …, 2018 - ncbi.nlm.nih.gov
Uveitic glaucoma consists one of the most serious complications of intraocular inflammation
and, despite its rarity, is considered as one of the leading causes of preventable loss of …

What causes steroid cataracts? A review of steroid‐induced posterior subcapsular cataracts

AI Jobling, RC Augusteyn - Clinical and experimental …, 2002 - Wiley Online Library
Prolonged use of glucocorticoids is a significant risk factor for the development of posterior
subcapsular cataract. This places restrictions on the use of glucocorticoids in the treatment …

Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor

VG Wong - US Patent 6,699,493, 2004 - Google Patents
Methods for reducing or preventing transplant rejection in the eye of an individual are
described, comprising: a) performing an ocular transplant procedure; and b) implant ing in …

Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs

EB Souto, S Doktorovova, E Gonzalez-Mira… - Current eye …, 2010 - Taylor & Francis
Due to the multiple barriers imposed by the eye against the penetration of drugs, the ocular
delivery and targeting are considered difficult to achieve. A major challenge in ocular drug …

Emerging treatment options for the management of pemphigus vulgaris

K Kridin - Therapeutics and clinical risk management, 2018 - Taylor & Francis
Pemphigus vulgaris (PV) is a life-threatening disease belonging to the pemphigus group of
autoimmune intra-epidermal bullous diseases of the skin and mucosae. The therapeutic …

Triamcinolone acetonide in ocular therapeutics

CM Jermak, JT Dellacroce, J Heffez… - Survey of ophthalmology, 2007 - Elsevier
Triamcinolone acetonide has been effectively used in ocular therapeutics for over 50 years.
Its use has increased dramatically in recent years for periocular and intraocular treatment of …

Association of inhaled corticosteroid use with cataract extraction in elderly patients

E Garbe, S Suissa, J LeLorier - Jama, 1998 - jamanetwork.com
Context.—The use of systemic corticosteroids is a known risk factor for the development of
cataracts. Objective.—To determine whether treatment with inhaled corticosteroids is …